Patients with complex medical histories, concurrent medications, or metabolic disorders should undergo thorough evaluation before starting any GLP-1 regimen, regardless of platform
Retatrutide is widely studied as a triple receptor agonist, engaging GLP-1, GIP, and glucagon pathways linked to metabolic regulation, appetite signalling, energy balance, glucose metabolism, lipid utilisation, and body composition research
People with colorectal cancer are screened for four proteins that help with DNA repair
PlexusDx pricing is flat per compound, not dose-based
Is bioidentical hormone therapy worth it
Like the plot of a 2000s teen movie, GLP-1 medications are like the main character who starts at a new school and becomes popular overnight